Investigating the Antimicrobial Activity, Cytotoxicity, and Action Mechanism of Acylated and Amidated Derivatives of AurH1 Antifungal Peptide

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2023 Nov 9

PMID 37946110

Authors

Reyhane Nikookar Golestani

Elahe Ghods

Mosayeb Rostamian

Hamid Madanchi

Ahmad Farhad Talebi

Affiliations

Soon will be listed here.

Abstract

Background: The increasing growth of microbial resistance threatens the health of human societies. Therefore, the discovery and design of new antibiotics seem necessary. Today, antimicrobial peptides (AMPs) are receiving attention due to their unique properties. In our previous studies, exclusive antifungal effects of AurH1, which is a truncated and modified form of Aurein1.2, were synthesized. In this study, AurH1 antifungal peptide was synthesized into acylated (Ac-AurH1) and amidated (AurH1-NH) derivatives, and their antifungal activity, cytotoxicity, anticancer activity, hemolytic effects were investigated. Finally, the time- of killing, the action mechanism of amidated and acylated peptides, and the effects of salts and human serum on their antimicrobial potency were determined. All the results obtained about these peptides were compared with the AurH1 without chemical modifications.

Results: The results showed that amidation at the C-terminal of AurH1 compared to acylation at the N-terminal of it can improve the antifungal properties and cytotoxicity of AurH1. The results showed that AurH1 amidation can maintain the antifungal activity of this peptide in the culture medium containing specific dilutions of human serum compared to the intact AurH1. Also, the amidation of the C-terminal of AurH1 could not affect the mechanism of action and its time -of killing.

Conclusion: As a result, the amidation of the C-terminal of the AurH1 is a suitable strategy to improve its antifungal properties and cytotoxicity. This modification can enhance its properties for animal studies.

Citing Articles

Novel Isoxazole-Based Antifungal Drug Candidates.

Bachor U, Brozyna M, Junka A, Chmielarz M, Gorczyca D, Maczynski M Int J Mol Sci. 2025; 25(24.

PMID: 39769380 PMC: 11728180. DOI: 10.3390/ijms252413618.

References

Madanchi H, Sardari S, Shajiee H, Taherian S, Ashkar M, Johari B . Design of new truncated derivatives based on direct and reverse mirror repeats of first six residues of Caerin 4 antimicrobial peptide and evaluation of their activity and cytotoxicity. Chem Biol Drug Des. 2020; 96(2):801-811. DOI: 10.1111/cbdd.13689. View

Kumar P, Pletzer D, Haney E, Rahanjam N, Cheng J, Yue M . Aurein-Derived Antimicrobial Peptides Formulated with Pegylated Phospholipid Micelles to Target Methicillin-Resistant Staphylococcus aureus Skin Infections. ACS Infect Dis. 2018; 5(3):443-453. DOI: 10.1021/acsinfecdis.8b00319. View

Fosgerau K, Hoffmann T . Peptide therapeutics: current status and future directions. Drug Discov Today. 2014; 20(1):122-8. DOI: 10.1016/j.drudis.2014.10.003. View

Waghu F, Joseph S, Ghawali S, Martis E, Madan T, Venkatesh K . Designing Antibacterial Peptides with Enhanced Killing Kinetics. Front Microbiol. 2018; 9:325. PMC: 5829097. DOI: 10.3389/fmicb.2018.00325. View

Chufan E, De M, Eipper B, Mains R, Amzel L . Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme. Structure. 2009; 17(7):965-73. PMC: 2993158. DOI: 10.1016/j.str.2009.05.008. View

Ciociola T, Giovati L, Conti S, Magliani W, Santinoli C, Polonelli L . Natural and synthetic peptides with antifungal activity. Future Med Chem. 2016; 8(12):1413-33. DOI: 10.4155/fmc-2016-0035. View

Namvar Erbani S, Madanchi H, Ajodani Far H, Rostamian M, Rahmati S, Shabani A . First report of antifungal activity of CecropinA-Magenin2 (CE-MA) hybrid peptide and its truncated derivatives. Biochem Biophys Res Commun. 2021; 549:157-163. DOI: 10.1016/j.bbrc.2021.02.106. View

Madanchi H, Ebrahimi Kiasari R, Seyed Mousavi S, Johari B, Shabani A, Sardari S . Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism. Probiotics Antimicrob Proteins. 2020; 12(4):1582-1593. DOI: 10.1007/s12602-020-09648-5. View

Memariani H, Shahbazzadeh D, Sabatier J, Memariani M, KarbalaeiMahdi A, Pooshang Bagheri K . Mechanism of action and in vitro activity of short hybrid antimicrobial peptide PV3 against Pseudomonas aeruginosa. Biochem Biophys Res Commun. 2016; 479(1):103-8. DOI: 10.1016/j.bbrc.2016.09.045. View

10.

Turecka K, Chylewska A, Kawiak A, Waleron K . Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of spp. Front Microbiol. 2018; 9:1594. PMC: 6058090. DOI: 10.3389/fmicb.2018.01594. View

11.

Hancock R . Host defence (cationic) peptides: what is their future clinical potential?. Drugs. 1999; 57(4):469-73. DOI: 10.2165/00003495-199957040-00002. View

12.

Prestinaci F, Pezzotti P, Pantosti A . Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015; 109(7):309-18. PMC: 4768623. DOI: 10.1179/2047773215Y.0000000030. View

13.

Madanchi H, Khalaj V, Jang S, Shabani A, Ebrahimi Kiasari R, Seyed Mousavi S . AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity. J Pept Sci. 2019; 25(7):e3175. DOI: 10.1002/psc.3175. View

14.

Madanchi H, Rahmati S, Doaei Y, Sardari S, Sadat Mousavi Maleki M, Rostamian M . Determination of antifungal activity and action mechanism of the modified Aurein 1.2 peptide derivatives. Microb Pathog. 2022; 173(Pt A):105866. DOI: 10.1016/j.micpath.2022.105866. View

15.

Kumar P, Kizhakkedathu J, Straus S . Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo. Biomolecules. 2018; 8(1). PMC: 5871973. DOI: 10.3390/biom8010004. View

16.

Madanchi H, Shoushtari M, Kashani H, Sardari S . Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases. New Microbes New Infect. 2020; 34:100627. PMC: 6976936. DOI: 10.1016/j.nmni.2019.100627. View

17.

Ahmadi K, Farasat A, Rostamian M, Johari B, Madanchi H . Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an drug repurposing study. J Biomol Struct Dyn. 2021; 40(12):5566-5576. PMC: 7814568. DOI: 10.1080/07391102.2021.1871958. View

18.

Madanchi H, Akbari S, Shabani A, Sardari S, Farahani Y, Ghavami G . Alignment-based design and synthesis of new antimicrobial Aurein-derived peptides with improved activity against Gram-negative bacteria and evaluation of their toxicity on human cells. Drug Dev Res. 2018; 80(1):162-170. DOI: 10.1002/ddr.21503. View

19.

Sharma R, Shrivastava S, Singh S, Kumar A, Saxena S, Singh R . Deep-AFPpred: identifying novel antifungal peptides using pretrained embeddings from seq2vec with 1DCNN-BiLSTM. Brief Bioinform. 2021; 23(1). DOI: 10.1093/bib/bbab422. View

20.

Wenzel M, Rudi Senges C, Zhang J, Suleman S, Nguyen M, Kumar P . Antimicrobial Peptides from the Aurein Family Form Ion-Selective Pores in Bacillus subtilis. Chembiochem. 2015; 16(7):1101-8. DOI: 10.1002/cbic.201500020. View